Correspondence
Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids
Riesgo de reactivación de la hepatitis B asociado al tratamiento con corticoides frente a SARS-CoV-2 (COVID-19)
J. Varona Pérez
, J.M. Rodriguez Chinesta
Corresponding author
Servicio de Medicina Interna, Hospital Universitario de Cruces. Barakado, Vizcaya, Spain
Read
1092
Timeswas read the article
179
Total PDF
913
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 7 | 0 | 7 |
| 2024 March | 12 | 0 | 12 |
| 2024 February | 5 | 0 | 5 |
| 2024 January | 10 | 0 | 10 |
| 2023 December | 13 | 0 | 13 |
| 2023 November | 30 | 0 | 30 |
| 2023 October | 24 | 0 | 24 |
| 2023 September | 21 | 0 | 21 |
| 2023 August | 19 | 1 | 20 |
| 2023 July | 24 | 1 | 25 |
| 2023 June | 21 | 0 | 21 |
| 2023 May | 28 | 3 | 31 |
| 2023 April | 26 | 0 | 26 |
| 2023 March | 25 | 4 | 29 |
| 2023 February | 22 | 6 | 28 |
| 2023 January | 26 | 3 | 29 |
| 2022 December | 31 | 3 | 34 |
| 2022 November | 35 | 3 | 38 |
| 2022 October | 27 | 7 | 34 |
| 2022 September | 17 | 2 | 19 |
| 2022 August | 22 | 5 | 27 |
| 2022 July | 32 | 4 | 36 |
| 2022 June | 20 | 3 | 23 |
| 2022 May | 25 | 2 | 27 |
| 2022 April | 32 | 5 | 37 |
| 2022 March | 31 | 6 | 37 |
| 2022 February | 29 | 7 | 36 |
| 2022 January | 38 | 9 | 47 |
| 2021 December | 45 | 7 | 52 |
| 2021 November | 19 | 2 | 21 |
| 2021 October | 10 | 4 | 14 |
| 2021 September | 24 | 4 | 28 |
| 2021 August | 37 | 7 | 44 |
| 2021 July | 20 | 10 | 30 |
| 2021 June | 18 | 8 | 26 |
| 2021 May | 14 | 8 | 22 |
| 2021 April | 19 | 4 | 23 |
| 2021 March | 5 | 2 | 7 |
| 2021 February | 3 | 3 | 6 |
| 2021 January | 4 | 12 | 16 |
| 2020 December | 9 | 10 | 19 |
| 2020 November | 13 | 5 | 18 |
| 2020 October | 3 | 2 | 5 |
| 2020 September | 3 | 5 | 8 |
| 2020 August | 9 | 7 | 16 |
| 2020 July | 6 | 5 | 11 |
Show all
